ROCHESTER, Minn. – The Mayo Clinic Cancer Center (MCCC) announced today that it has received an overall "exceptional" score on the competitive renewal of its National Cancer Institute (NCI) Cancer Center Support Grant (CCSG). The grant award will provide roughly $28.6 million in funding over five years, providing essential support for the MCCC's 10 research programs and 13 shared resources through 2018.
The MCCC's NCI designation as a comprehensive cancer center was also renewed. To earn the comprehensive cancer center designation, an institution must participate in multidisciplinary laboratory, clinical and population-based research and educate the community it serves about research advances. There are 41 NCI-designated comprehensive cancer centers across the country. The MCCC is the only single comprehensive cancer center with three geographic sites – in Phoenix/Scottsdale, Ariz.; Jacksonville, Fla., and Rochester, Minn.
"Exceptional" is the highest rating given by the NCI. Fewer than 10 percent of NCI-designated cancer centers receive "exceptional" scores.
"This rating reflects the level of science being conducted by our researchers and the high quality of our staff," says MCCC director, Robert Diasio, M.D.